Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding.

Annals of Surgical Innovation and Research
Steven D HughesW Allan Alexander

Abstract

This study was designed to evaluate the effect of recombinant human thrombin (rThrombin) concentration on time to hemostasis (TTH), clot durability, and clot strength in settings that replicate the heparinization and platelet inhibition often found in surgical populations. A modified, anticoagulated rabbit arteriovenous shunt preparation was selected to model vascular anastomotic bleeding. Rabbits were treated with heparin or heparin + clopidogrel and TTH was measured after applying a range of topical rThrombin concentrations or placebo, in combination with absorbable gelatin sponge, USP. Treatments (placebo, rThrombin) were randomly assigned and the investigator was blinded to treatment. TTH was evaluated with the Kaplan-Meier method. After hemostasis was achieved, clot burst assessment was performed for heparin + clopidogrel treated animals. Clot viscoelastic strength and kinetics were measured in ex-vivo samples using thromboelastography (TEG) methods. TTH decreased with increasing concentrations of rThrombin in heparin-treated animals and was shorter after treatment with 1000 IU/mL rThrombin (73 seconds) than with 125 IU/mL rThrombin (78 seconds; p = 0.007). TTH also decreased with increasing concentrations of rThrombin in ...Continue Reading

References

Jul 27, 1989·Biochimica Et Biophysica Acta·B BlombäckN Aslund
Apr 30, 2004·Thrombosis and Haemostasis·Roger L LundbladKenneth G Mann
Aug 3, 2004·Nature Reviews. Drug Discovery·Paul Bishop, Jeff Lawson
May 5, 2006·Seminars in Thrombosis and Hemostasis·Paul D BishopKathleen M Walker
Sep 15, 2006·Regulatory Toxicology and Pharmacology : RTP·Jane K HeffernanMark C Rogge
Jan 9, 2007·Blood Reviews·Alisa S Wolberg
Nov 6, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Taro TaketomiKenichi A Tanaka
Feb 7, 2008·JAMA : the Journal of the American Medical Association·P Michael HoJohn S Rumsfeld
Aug 5, 2009·Journal of the American College of Surgeons·Neil K SinglaW Allan Alexander
Jan 20, 2010·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Mark J WehrumMichael J Paidas

❮ Previous
Next ❯

Citations

May 29, 2012·Research in Veterinary Science·Chad W SchmiedtBenjamin M Brainard
Feb 11, 2020·Journal of Cardiovascular Pharmacology·Qiu-Ling WuWei-Dong Zhang

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.